{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T16:08:18Z","timestamp":1772986098896,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jpba.2023.115653","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T03:01:26Z","timestamp":1692414086000},"page":"115653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["QuEChERS-assisted ion pair chromatography\/fluorescence detection method for determination of antimigraine combination therapy in rabbit plasma samples: Application to a pharmacokinetic study"],"prefix":"10.1016","volume":"235","author":[{"given":"Azza H.","family":"Rageh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pakinaz Y.","family":"Khashaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally A.","family":"El Zohny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noha N.","family":"Atia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2023.115653_bib1","article-title":"Genetic variants related to successful migraine prophylaxis with verapamil","volume":"9","author":"Cutrer","year":"2021","journal-title":"Mol. Genet. Genom. Med."},{"key":"10.1016\/j.jpba.2023.115653_bib2","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2147\/NDT.S3497","article-title":"Prophylaxis of migraine: general principles and patient acceptance","volume":"4","author":"D\u2019Amico","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jpba.2023.115653_bib3","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1517\/17425255.2012.701618","article-title":"Pharmacokinetic evaluation of zolmitriptan for the treatment of migraines","volume":"8","author":"Lionetto","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jpba.2023.115653_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11940-010-0105-6","article-title":"Acute migraine therapy: new drugs and new approaches","volume":"13","author":"Monteith","year":"2011","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.jpba.2023.115653_bib5","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1111\/bph.12651","article-title":"Modelling headache and migraine and its pharmacological manipulation","volume":"171","author":"Erdener","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jpba.2023.115653_bib6","first-page":"1","article-title":"Migraine triggers: an overview of the pharmacology, biochemistry, atmospherics, and their effects on neural networks","author":"Kesserwani","year":"2021","journal-title":"Cureus 13"},{"key":"10.1016\/j.jpba.2023.115653_bib7","first-page":"283","article-title":"Beta blocker eye drops for treatment of acute migraine","volume":"111","author":"Migliazzo","year":"2014","journal-title":"Mo. Med."},{"key":"10.1016\/j.jpba.2023.115653_bib8","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1517\/13543784.10.10.1831","article-title":"Advances in pharmacological treatment of migraine","volume":"10","author":"Diener","year":"2001","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.jpba.2023.115653_bib9","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/jamaophthalmol.2020.3676","article-title":"Short-term efficacy and safety of topical \u03b2-blockers (timolol maleate ophthalmic solution, 0.5%) in acute migraine a randomized crossover trial","volume":"138","author":"Kurian","year":"2020","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.jpba.2023.115653_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1468-2982.1997.1702073.x","article-title":"Migraine prophylactic drugs: proof of efficacy, utilization and cost","volume":"17","author":"Ramadan","year":"1997","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jpba.2023.115653_bib11","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1067\/mcp.2000.106292","article-title":"Pharmacokinetic interaction between verapamil and almotriptan in healthy volunteers","volume":"67","author":"Fleishaker","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2023.115653_bib12","first-page":"133","article-title":"Utility of brominating agent and methyl orange for spectrophotometric determination of Almotriptan in pharmaceutical tablets; applying of content uniformity measurement","volume":"11","author":"Mahmoud","year":"2018","journal-title":"ChemXpress"},{"key":"10.1016\/j.jpba.2023.115653_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7598\/cst2012.181","article-title":"Development of new visible spectrophotometric methods for quantitative determination of almotriptan malate using quinones as chromogenic reagents","volume":"1","author":"Bab","year":"2012","journal-title":"Chem. Sci. Trans."},{"key":"10.1016\/j.jpba.2023.115653_bib14","first-page":"379","article-title":"Quantitative assay of almotriptan malate in pure drug and pharmaceutical preparations using simple and convenient visible spectrophotometric methods","volume":"3","author":"Prasad","year":"2012","journal-title":"Int. J. Pharma Sci. Res. (IJPSR)"},{"key":"10.1016\/j.jpba.2023.115653_bib15","first-page":"747","article-title":"A simple spectrophotometric assay of almotriptan malate in bulk and pharmaceutical formulations","volume":"5","author":"Prabhavthi","year":"2016","journal-title":"World J. Pharm. Res."},{"key":"10.1016\/j.jpba.2023.115653_bib16","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1039\/c3ay41842a","article-title":"Highly sensitive spectrofluorimetric method for the determination of two antimigraine drugs in their tablets and in biological fluids. Application to content uniformity testing","volume":"6","author":"Belal","year":"2014","journal-title":"Anal. Methods"},{"key":"10.1016\/j.jpba.2023.115653_bib17","first-page":"497","article-title":"Validation of rapid and sensitive spectrofluorimetric assay for determination of four triptans in pure and dosage forms; application to human plasma and content uniformity testing","volume":"7","author":"Hammad","year":"2016","journal-title":"Pharm. Anal. Acta"},{"key":"10.1016\/j.jpba.2023.115653_bib18","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1002\/elan.201300335","article-title":"Fabrication of an electrochemical sensor based on multiwalled carbon nanotubes for almotriptan","volume":"25","author":"Narayan","year":"2013","journal-title":"Electroanalysis"},{"key":"10.1016\/j.jpba.2023.115653_bib19","doi-asserted-by":"crossref","DOI":"10.4137\/ACI.S8864","article-title":"Two chromatographic methods for the determination of some antimigraine drugs","volume":"7","author":"El-Bagary","year":"2012","journal-title":"Anal. Chem. Insights"},{"key":"10.1016\/j.jpba.2023.115653_bib20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3797\/scipharm.1112-01","article-title":"Method development and validation of almotriptan in human plasma by HPLC tandem mass spectrometry: Application to pharmacokinetic study","volume":"80","author":"Ravikumar","year":"2012","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.jpba.2023.115653_bib21","first-page":"183","article-title":"High performance liquid chromatographic analysis of almotriptan malate in bulk and tablets","volume":"3","author":"Lavudu","year":"2013","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.jpba.2023.115653_bib22","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jpba.2007.11.029","article-title":"A validated reversed phase HPLC method for the determination of process-related impurities in almotriptan malate API","volume":"46","author":"Kumar","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115653_bib23","first-page":"291","article-title":"Estimation of almotriptan malate in oral film dosage form by RP-HPLC","volume":"7","author":"Kothapuvari","year":"2015","journal-title":"Der Pharm. Lett."},{"key":"10.1016\/j.jpba.2023.115653_bib24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jchromb.2016.02.031","article-title":"Development and validation of a liquid chromatography-tandem mass spectrometric assay for quantitative analyses of triptans in hair","volume":"1017\u20131018","author":"Vandelli","year":"2016","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2023.115653_bib25","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jpba.2013.04.008","article-title":"LC-MS\/MS method for the quantification of almotriptan in dialysates: application to rat brain and blood microdialysis study","volume":"81\u201382","author":"Nirogi","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115653_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jchromb.2012.02.017","article-title":"LC-ESI-MS\/MS determination of in vivo metabolites of almotriptan in rat plasma, urine and feces: application to pharmacokinetics","volume":"891\u2013892","author":"Nageswara Rao","year":"2012","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2023.115653_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/bdd.412","article-title":"Pharmacokinetics and safety of oral almotriptan in healthy male volunteers","volume":"25","author":"McEwen","year":"2004","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.jpba.2023.115653_bib28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/10408340802038882","article-title":"Ion pairing chromatography","volume":"38","author":"Cecchi","year":"2008","journal-title":"Crit. Rev. Anal. Chem."},{"key":"10.1016\/j.jpba.2023.115653_bib29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0021-9673(99)00526-9","article-title":"Reversed-phase ion-pair chromatography coupled to electrospray ionisation mass spectrometry by on-line removal of the counter-ions","volume":"854","author":"Forngren","year":"1999","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2023.115653_bib30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/chromsci\/15.9.413","article-title":"Practical aspects off reverse phase ion pair chromatography","volume":"15","author":"Gloor","year":"1977","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jpba.2023.115653_bib31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jchromb.2016.08.040","article-title":"Green approaches in sample preparation of bioanalytical samples prior to chromatographic analysis","volume":"1043","author":"Filippou","year":"2017","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2023.115653_bib32","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1515\/chem-2015-0109","article-title":"A review of recent developments and trends in the QuEChERS sample preparation approach","volume":"13","author":"Rejczak","year":"2015","journal-title":"Open Chem."},{"key":"10.1016\/j.jpba.2023.115653_bib33","unstructured":"Guideline for Industry: Text on Validation of Analytical Procedures: ICH-Q2A, U.S. Department of Health and Human Services, Public Health Service, Food and Drug Administration, 1995."},{"key":"10.1016\/j.jpba.2023.115653_bib34","doi-asserted-by":"crossref","unstructured":"Guidance for industry: bioanalytical method validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 2001. https:\/\/doi.org\/https:\/\/doi.org\/10.4155\/bio.13.298.","DOI":"10.4155\/bio.13.298"},{"key":"10.1016\/j.jpba.2023.115653_bib35","doi-asserted-by":"crossref","unstructured":"J.S. Fritz, D.T. Gjerde, Ion Chromatography: Mechanisms, John Wiley & Sons, 2009.","DOI":"10.1002\/9783527626878"},{"key":"10.1016\/j.jpba.2023.115653_bib36","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1021\/ac00041a027","article-title":"Chromatographic characteristics of surfactant-mediated separations: micellar liquid chromatography vs ion pair chromatography","volume":"64","author":"Kord","year":"1992","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2023.115653_bib37","unstructured":"D. Corradini, E.E. (Katz), R. Eksteen, P. Schoenmakers, N. Miller, Handbook of HPLC, CRC Press, 2011."},{"key":"10.1016\/j.jpba.2023.115653_bib38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jpba.2016.05.007","article-title":"Mixed-mode chromatography in pharmaceutical and biopharmaceutical applications","volume":"128","author":"Zhang","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115653_bib39","doi-asserted-by":"crossref","first-page":"8813","DOI":"10.1016\/j.chroma.2011.10.009","article-title":"Mixed-mode chromatography and its applications to biopolymers","volume":"1218","author":"Yang","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2023.115653_bib40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0021-9673(03)00537-5","article-title":"Analysis and critical comparison of the reversed-phase and ion-exchange contributions to retention on polybutadiene coated zirconia and octadecyl silane bonded silica phases","volume":"996","author":"Yang","year":"2003","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2023.115653_bib41","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.chroma.2013.09.079","article-title":"Imidazolium-based ionic liquid-type surfactant as pseudostationary phase in micellar electrokinetic chromatography of highly hydrophilic urinary nucleosides","volume":"1316","author":"Rageh","year":"2013","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2023.115653_bib42","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10337-018-3477-5","article-title":"Characterization of retention mechanisms in mixed-mode HPLC with a bimodal reversed-phase\/cation-exchange stationary phase","volume":"81","author":"Lemasson","year":"2018","journal-title":"Chromatographia"},{"key":"10.1016\/j.jpba.2023.115653_bib43","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/jssc.200900645","article-title":"HILIC behavior of a reversed-phase\/cationexchange\/ anion-exchange trimode column","volume":"33","author":"Liu","year":"2010","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2023.115653_bib44","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.talanta.2019.02.082","article-title":"Selectivity enhanced cation exchange chromatography for simultaneous determination of peptide variants","volume":"199","author":"Ahmed","year":"2019","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2023.115653_bib45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.trac.2015.04.012","article-title":"Evolution and applications of the QuEChERS method","volume":"71","author":"Gonz\u00e1lez-Curbelo","year":"2015","journal-title":"TrAC - Trends Anal. Chem."},{"key":"10.1016\/j.jpba.2023.115653_bib46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.chroma.2014.01.024","article-title":"Rapid and simple extraction of lipids from blood plasma and urine for liquid chromatography-tandem mass spectrometry","volume":"1331","author":"Bang","year":"2014","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2023.115653_bib47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.17145\/rss.20.003","article-title":"Innovative approach to increase sensibility and selectivity in analytical chemistry: QuEChERS method","volume":"2","author":"Tartaglia","year":"2020","journal-title":"Rev. Sep. Sci."},{"key":"10.1016\/j.jpba.2023.115653_bib48","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.talanta.2015.08.021","article-title":"Simultaneous extraction and cleanup of high-lipid organs from white sturgeon (Acipenser transmontanus) for multiple legacy and emerging organic contaminants using QuEChERS sample preparation","volume":"146","author":"Morrison","year":"2016","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2023.115653_bib49","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/jaoac\/86.2.412","article-title":"Fast and easy multiresidue method employing acetonitrile extraction\/partitioning and \u201cdispersive solid-phase extraction\u201d for the determination of pesticide residues in produce","volume":"86","author":"Anastassiades","year":"2003","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.jpba.2023.115653_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.aca.2019.02.036","article-title":"QuEChERS - fundamentals, relevant improvements, applications and future trends","volume":"1070","author":"Perestrelo","year":"2019","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2023.115653_bib51","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2125.1997.t01-1-00632.x","article-title":"The interaction between propranolol and the novel antimigraine agent zolmitriptan (311C90)","volume":"44","author":"Peck","year":"1997","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2023.115653_bib52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0090-9556(24)15007-6","article-title":"Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humans","volume":"28","author":"Vyas","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2023.115653_bib53","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1365-2125.2001.01367.x","article-title":"Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans","volume":"51","author":"Fleishaker","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2023.115653_bib54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.0306-5251.2001.01417.x","article-title":"Infuence of B-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B\/1D agonist: differential effects of propranolol, nadolol and metoprolol","author":"Goldberg","year":"2001","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523004223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523004223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:34:32Z","timestamp":1760002472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708523004223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":54,"alternative-id":["S0731708523004223"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115653","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"QuEChERS-assisted ion pair chromatography\/fluorescence detection method for determination of antimigraine combination therapy in rabbit plasma samples: Application to a pharmacokinetic study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115653"}}